Using Agonists and Antagonists in IVF: An Opinion
702-892-9696
Fax:
702-892-9666
The main objective in controlled ovarian stimulation (COS) is of course, to safely optimize egg quantity without compromising quality. For this to be achieved, COS must of necessity strike a balance in the administration of the pituitary gland-derived hormones, luteinizing hormone (LH) and follicle stimulating hormone (FSH).
When it comes to influencing IVF outcome, the protocol selected for COS is the most critical decision that the treating fertility doctor can make. There is no more a standard protocol applicable to all IVF candidates than there is a standard height or weight for any individual. Each woman should be independently evaluated for the optimal COS protocol. Such an assessment should take into account the woman’s age, her ovarian reserve (as assessed by basal blood FSH, LH, estradiol and in many cases also the AMH), her previous response to ovarian stimulation, and the cause of the infertility. This article seeks to establish a rational basis for how the interaction between pituitary gonadotropins (follicle stimulating hormone [FSH] and luteinizing hormone [LH]) and agonists/antagonists can affect egg/embryo quality and ultimately impact IVF outcome.
How LH and FSH promote follicle growth and egg development: LH causes the connective tissue (theca/stroma) that surrounds the ovarian follicles to produce and release androgens (male hormones)…mainly testosterone. These androgens are then transported to the (granulosa) cells that line the inner ovarian follicles, where FSH then causes the conversion of (predominantly) testosterone to estradiol. As a result, the follicles grow, blood estrogen levels rise, and eggs undergo the developmental change (ovogenesis) necessary to allow proper preovulatory maturation triggered by the LH surge or by the administration of human chorionic gonadotropins (hCG).
While some androgen-testosterone is an essential prerequisite for normal follicular development, estradiol production and ovogenesis, an excess of androgens can overload and exhaust granulosa cells, overtax egg development and ultimately lead to egg chromosomal irregularities (i.e., aneuploidy). Upon being fertilized, aneuploid eggs invariably propagate embryos that are aneuploid and “incompetent” (i.e., incapable of developing normally). Such aneuploid embryos will invariably either arrest during development, fail to implant in the uterus, miscarry, or develop into chromosomally compromised offspring (e.g., Down Syndrome).
Long agonist pituitary down-regulation protocols: Within a few hours of administering an agonist (e.g., leuprolide, Buserelin, Nafarelin, Synarel), most LH is promptly expunged from pituitary gland reservoirs. The result….high blood LH concentrations, and consequential release of large amounts of androgens (mainly testosterone). The continued administration of agonists will ultimately exhaust pituitary LH reservoirs such that within a few days, blood LH concentration will decline, and over-production of ovarian androgens will thereby be avoided.
Long pituitary down-regulation protocols involve the administration of an agonist over four or more days prior to initiating ovarian stimulation with FSH-containing gonadotropins (e.g., Follistim, Gonal-F, Puregon). These protocols take advantage of this LH-depleting effect such that by the time COS with gonadotropins is initiated, the blood LH will be low enough to avoid over-production of ovarian androgens and thereby help protect follicle and egg development.
Short (flare/microflare) agonist protocols: This type of protocol involves commencing agonist administration at the time that FSH-gonadotropin therapy is initiated. This will usually result in a high (excessive) concentration of androgens bombarding follicle- granulosa cells from the very onset of COS…to the ultimate determent of egg/embryo “competency.” Since older women, those who have diminished ovarian reserve (DOR) and those with polycystic ovarian syndrome (PCOS) tend to have exaggerated pituitary LH production and/or activity leading to overgrowth of androgen-producing ovarian theca/stroma (hyperthecosis), they are the ones who are most susceptible to the adverse effects of agonist-induced, exaggerated LH-testosterone production caused by short (flare/microflare) protocols. Thus, in my opinion, it is prudent to avoid using this protocol, especially in such vulnerable individuals.
Antagonist protocols: There is another group of drugs that rapidly blocks the release of gonadotropins (FSH/LH) by the pituitary gland. These so called antagonists (e.g., Ganirelix, Cetrotide, Orgalutron) are traditionally administered starting 6-8 days after the initiation of controlled ovarian stimulation (COS). I believe that this might be all well and good with COS in younger women that have normal ovarian reserve and in whom LH activity is not excessive. However, the initiation of an antagonist LH blockade starting as late as 6-8 days after COS is started fails to protect early developing follicles and eggs from the potentially ravaging effects of over exposure to LH-induced ovarian androgens. Thus, in my opinion, it is preferable to commence antagonist therapy at the point that COS with gonadotropins is initiated, rather than starting a week or so thereafter.
Clomiphene and Letrozole: Similarly, since fertility drugs such as Clomiphene (Serophene/Clomid) and Letrazole (Femara) also cause increased release of pituitary LH, they are, in my opinion, best avoided in the IVF setting.
LH-containing menotropins: For the same reasons , the use of gonadotropins such as Menopur, that have a considerable amount of LH activity should in my opinion be limited in IVF, especially when it comes to older women, those with DOR and women who have PCOS. I submit that it is at all times preferable to predominantly use FSH-dominant, recombinant DNA-derived Follistim, Puregon and Gonal-F than to use LH-containing menotropins.
11 Responses to “Using Agonists and Antagonists in IVF: An Opinion”
Leave a Reply
Top Search Terms for In Vitro Fertilization
- Embryo Quality & Embryo “Competence” – Part III – Testing the Seed
- Embryo Quality & Embryo “Competence” – Part One: Planting a Good Seed
- The Needle vs. the Dish: Should ICSI Be Used in All IVF?
- Embryo Implantation: What Farmers Can Teach us About Growing Healthy Babies
- Acupuncture and IVF: Does it Improve Success?
Ask Our DoctorsA Question












Age 37-38 I’ve had horrible response to the antagonist protocol with few follicles and uneven size. Responsed ok to first microflare but required huge doses of fsh (600 x 11 days), 5 eggs retrieved. Later continued same microflare with half dose of fsh with menopur, got 9 eggs (8 fertilized)
Repeated again with slightly less fsh and menopur, retrieved 17 but only 8 fertilized. Has to freeze at day 3 due to high e2 of 7500, 4 thawed but three were quite fragmented.
Other than control of high testosterone/dhea level, no other change.
What thought on such variability
Frankly, I do not use “flare protocols” because inevitably they result in an elevated LH-induced testosterone level. See below.
Please go to the home page of this blog, (www.IVFauthority.com). When you get there look for a “search bar” in the upper right hand column. Then type in the following subjects into the bar, click and this will take you to all the relevant articles I posted there.
1. “An Individualized Approach to Ovarian stimulation” (posted on November 22nd, 2010)
2. “Ovarian Stimulation in IVF: Why is it important to down-regulate LH?”
3. “Agonist/Antagonist Conversion Protocol”
Consider calling 800-780-7437 or 702-699-7437 to arrange a Skype consultation (free of charge to those who reside in the United States or Canada) with me so we can discuss your case in detail.
Geoff Sher
Hello Dr. Sher,
I’ve been trying to get pregnant since I was 33 – now I’m 36. Husband is 44 (no previous kids) Spermogram is NORMAL. We’ve NEVER been pregnant.
High prolactin controlled by 2.5mg bromocriptine daily since 2012 (13.7 in April 2013)
7 failed IUI (3 with Clomid and Ovidrel; 4 only with Ovidrel)
FSH = 8 in March 2011; FSH = 13.7 in Dec 2012 AMH = 0.53 in Dec 2012
IVF#1 failed (March 2013) with 11 follicles> 4 eggs> 2 embryos (8cells – average quality; 4cells – low quality; both transferred on day 3) PROTOCOL: Birth Control Pill for 19 days, 200mcg Naferelyn (twice a day) for 12 days, 300 IU Puregon and 300 IU Menopur for 12 days; and triggered with 0.5 ml Ovidrel. PLUS: 40mg Enaxoparin after egg collection (clotting problems); Dexamethazone for 12 days during stimulation and Methylprednisolone for 4 days after egg collection.
Since I have noticeable low ovarian reserve and I had low response to medications I visited different clinics to know what could be my best option for IVF #2
1) Same clinic as IVF#1 – same protocol as IVF#1 – what is new: Dr. is considering Intra-lipids and 5mg Prednisone from day 1 of stimulation to the 1st trimester of pregnancy (suspecting embryo rejection problems); 1 IU growth hormone (Saizen) for 30 days from the day 1 of contraceptives; trigger with 2 injections of ovidrel instead of 1. QUESTIONS: is Prednisone and Dexamethazone together too much cortisone? Is cortisone plus intra-lipids too much? They prescribe this after a test showing 13% Natural Killer Cells. Is this the highest dose of hormones?
2) Going to Antagonist protocol – I was said in one clinic that I may respond better to this protocol. WHAT DO YOU THINK?
3) Natural IVF Cycle – I was said that since I had low response to hormone stimulations, then I should try just Natural IVF. WHAT DO YOU THINK?
4) Egg donation – SHOULD I TRY WITH MY OWN STILL?
Thanks in advance Doctor for any advice we are so confused, too many information, tired of negative results. No unlimited money to try all of the options.
You definitely have diminished ovarian reserve and this in combination with protocols that do not control ovarian LH-induced testosterone, in my opinion wont be optimal. I think your choices are 1) Aggressive stimulation on an agonsist/antagonist conversion protocol (LA-8), followed by selective embryo banking of CGH-normal blastocysts over several cycles versus ..2) IVF with egg donation. In either case, it would be advisable to also evaluate for possible autoimmune/alloimmune implantation dysfunction from the get-go.
Please go to the home page of this blog, http://www.IVFauthority.com . When you get there, look for a “search bar” in the upper right hand corner. Type the following subjects into the bar, click on it and it will take you to all the relevant articles posted there.
1. “An Individualized Approach to Ovarian stimulation” (posted on November 22nd, 2010)
2. “Ovarian Stimulation in IVF: Why is it important to down-regulate LH?”
3. “Agonist/Antagonist Conversion Protocol”
4. “Immunologic Implantation Dysfunction” (posted on May, 10th and on May 16th respectively.
5. “Embryo Implantation………” (Part-1 and Part- 2—-Posted August 2012)
6. “Traveling for IVF from Out of State/Country– The Process at SIRM-Las Vegas” (posted on March, 21st 2012)
7.“A personalized, stepwise approach to IVF at SIRM”; Parts 1 & 2 (posted March, 2012)
8. “IVF success: Factors that influence outcome”
9. “Staggered IVF”
10.“Embryo Banking”
11. “Egg Donation”
Consider calling 800-780-7437 or 702-699-7437 to arrange a Skype consultation (free of charge to those who reside in the United States or Canada) with me so we can discuss your case in detail
Geoff Sher
Dear Dr Sher,
I am very intrested in your opinion. I will be doing the long protocol soon with the buserelin supression. Because of this, by the time i start my stimulation meds my LH will be close to zero as value so this will avoid over-production of ovarian androgens. In this case will i still need to have a half dose menopur (37.5) starting day 3 of meds or because the LH is already very low I can start menopur 75 on day 1 or 3 of stims?
I am 35 years old with normal ovarian reserve and a normal responder to meds ( day 3 FSH is 6 and AFC 17 )
Thank you very much,
Emma
Your LH will of course be suppressed with the Buserelin…but not totally. The Menopur adds a little LH (needed) from day 3 of stim and that is quite adequate.
good luck!
Geoff Sher
Thank you so much Dr Sher! Will you suggest adding on day 3 menopur 37.5ui or go with a vial of 75ui.
Usually I stim for 9 days and I will be on 200 ui puregon.
Kind regards,
Emma
75 is OK!
Geoff Sher
I am 33 years old, with an AFC of approximately 25. I get pregnant with un-medicated IUIs (3/4 attempts), but have lost all pregnancies around 8 weeks (1 chromosomally normal embryo, 2 with aneuploidies). I may have PCOS (based on a large number of follicles and elevated DHEAS), but everything else is bang normal. My LH is low (2.5 ng/ml) on CD3, and seems to rise normally, peaking on only on the day of the surge.
Despite my limited success at IUIs, my first IVF (with the microflare protocol and menagon) was a disaster: 11 eggs, 4 M2s, and 1 day 5 embryo 3AA grade embryo that failed to implant in my surrogate.
I am going back for another round of IVF; I’m switching to low-dose follistim, but I’m conflicted about when to start the antagonist. I see your point about a high LH level being bad, but I’m also concerned about a possibly deleterious effect on egg quality if LH is completely absent. From all indications, it does not appear to be high in the early days of my natural cycle.
I’m curious about how entirely the antagonist suppresses LH production. Is there a little occurring anyway? If taking LH separately with the follistim and the antagonist, what dose do you recommend?
LH activity will not be completely absent if you add a little Menopur from day 3 of stimulation…forward. Of greater concern is the possibility of a hitherto undiagnosed implantation issue.Please go to the Home page of this blog, http://www.IVFauthority.com. When you get there, look for the “search bar” in the upper right hand corner. Type the following subjects into the bar, click on it and it will take you to all the relevant articles posted there.
1. “An Individualized Approach to Ovarian stimulation” (posted on November 22nd, 2010)
2. “Ovarian Stimulation in IVF: Why is it important to down-regulate LH?”
3. “Agonist/Antagonist Conversion Protocol”
4. “Immunologic Implantation Dysfunction” (posted on May, 10th and on May 16th respectively.
5. “Embryo Implantation………” (Part-1 and Part- 2—-Posted August 2012)
6. “Traveling for IVF from Out of State/Country– The Process at SIRM-Las Vegas” (posted on March, 21st 2012)
7.“A personalized, stepwise approach to IVF at SIRM”; Parts 1 & 2 (posted March, 2012)
I invite you to call 800-780-7437 or 702-699-7437 to arrange a Skype consultation (free of charge to those who reside in the United States or Canada) with me so we can discuss your case in detail
Geoff Sher
Thank you so much for your feedback. I am a little puzzled as to why you think an implantation issue may be indicated in me; I’ve managed to get pregnant 3 times (out of 4 unmedicated attempts), and one of those times was with a embryo with Trisomy 4, which makes one think that my uterus is extremely receptive. There was a study which explored this concept recently: http://www.ncbi.nlm.nih.gov/pubmed/22848492
Additionally, in my IVF cycle, my one day 5 embryo was transferred to my surrogate.
Nonetheless, I’d love to arrange a consultation, I will be in touch.